Artimplant has signed licensing agreement with Small Bone Innovations, Inc. (SBi) for all joints in the hand and wrist domain. The license is exclusive and global (except for the Nordic countries) and covers resurfacing with Artelon®, a concept that contributes to regenerating function in joints that have degenerated functionality due to osteoarthritis. In addition to the license for joints in the hand and wrist, Artimplant is entitled to transfer to SBi, and SBi is entitled to require Artimplant to transfer the ownership of existing product clearances of Artelon® CMC Spacer, Artelon® CMC Spacer Arthro, Artelon® STT Spacer and Artelon® DRU Spacer to SBi. The Artelon® Resurfacing concept creates the preconditions for the body to heal itself. The thought is pioneering; a minimal resection of the joint afflicted by osteoarthritis creates the preconditions for integration of tissue in the Artelon®-implant, thus creating a new joint surface. The patient regains a functional joint. |
